These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32878646)

  • 21. Laparoscopic pelvic exenteration and laterally extended endopelvic resection for postradiation recurrent cervical carcinoma: Technical feasibility and short-term oncologic outcome.
    Kanao H; Aoki Y; Omi M; Nomura H; Tanigawa T; Okamoto S; Chang EJ; Kurita T; Netsu S; Matoda M; Omatsu K; Matsuo K
    Gynecol Oncol; 2021 Apr; 161(1):34-38. PubMed ID: 33423805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery.
    Caceres A; Mourton SM; Bochner BH; Gerst SR; Liu L; Alektiar KM; Kardos SV; Barakat RR; Boland PJ; Chi DS
    Int J Gynecol Cancer; 2008; 18(5):1139-44. PubMed ID: 18053063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
    Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pelvic exenteration in clear cell adenocarcinoma of the vagina and cervix.
    Senekjian EK; Frey K; Herbst AL
    Gynecol Oncol; 1989 Sep; 34(3):413-6. PubMed ID: 2767532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort.
    Straubhar AM; Chi AJ; Zhou QC; Iasonos A; Filippova OT; Leitao MM; Awowole IO; Abu-Rustum NR; Broach VA; Jewell EL; Sandhu JS; Sonoda Y
    Gynecol Oncol; 2021 Nov; 163(2):294-298. PubMed ID: 34518053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review].
    Sardain H; Lavoué V; Foucher F; Levêque J
    J Gynecol Obstet Biol Reprod (Paris); 2016 Apr; 45(4):315-29. PubMed ID: 26874666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix.
    Shingleton HM; Soong SJ; Gelder MS; Hatch KD; Baker VV; Austin JM
    Obstet Gynecol; 1989 Jun; 73(6):1027-34. PubMed ID: 2726106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of distance to closest negative margin on survival after pelvic exenteration.
    Martin AL; Sinha S; Peres LC; Hakam A; Chon HS; Hoffman MS; Shahzad MM; Wenham RM; Chern JY
    Gynecol Oncol; 2022 Jun; 165(3):514-521. PubMed ID: 35487774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors in pelvic exenteration for gynecological malignancies.
    Baiocchi G; Guimaraes GC; Rosa Oliveira RA; Kumagai LY; Faloppa CC; Aguiar S; Begnami MD; Soares FA; Lopes A
    Eur J Surg Oncol; 2012 Oct; 38(10):948-54. PubMed ID: 22818842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pelvic Exenteration for Anal and Urogenital Squamous Cell Carcinoma: Experience and Outcomes from an Exenteration Unit Over 12 Years.
    Smith N; Waters PS; Peacock O; Kong JC; McCormick J; Warrier SK; McNally O; Lynch AC; Heriot AG
    Ann Surg Oncol; 2020 Jul; 27(7):2450-2456. PubMed ID: 31993856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined laparoscopic and transperineal endoscopic total pelvic exenteration for the vaginal stump recurrence of cervical cancer.
    Ohno R; Matsumoto Y; Nagano H; Komono A; Aisu N; Yoshimatsu G; Hasegawa S
    J Gynecol Oncol; 2022 Jan; 33(1):e16. PubMed ID: 34910397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is a Vaginectomy Enough or is a Pelvic Exenteration Always Required for Surgical Treatment of Recurrent Cervical Cancer? A Propensity-Matched Study.
    Vizzielli G; Tortorella L; Conte C; Chiantera V; Gallotta V; Foschi N; Arcieri M; Ferrandina G; Fagotti A; Zattoni F; Scambia G; Ercoli A
    Ann Surg Oncol; 2021 Jun; 28(6):3281-3290. PubMed ID: 33063258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exenteration as a primary treatment for locally advanced cervical cancer: long-term results and prognostic factors.
    Forner DM; Lampe B
    Am J Obstet Gynecol; 2011 Aug; 205(2):148.e1-6. PubMed ID: 21640963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Robot-assisted laparoscopy in the management of recurrent pelvic cancer].
    Jauffret C; Lambaudie E; Bannier M; Buttarelli M; Houvenaeghel G
    Gynecol Obstet Fertil; 2011 Dec; 39(12):674-80. PubMed ID: 21871833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pelvic exenterations for gynecological malignancies: a study of 36 cases.
    Kaur M; Joniau S; D'Hoore A; Van Calster B; Van Limbergen E; Leunen K; Penninckx F; Van Poppel H; Amant F; Vergote I
    Int J Gynecol Cancer; 2012 Jun; 22(5):889-96. PubMed ID: 22617477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical treatment of locally advanced and recurrent cervical carcinoma: overview on current standard and new developments.
    Höckel M
    Onkologie; 2003 Oct; 26(5):452-5. PubMed ID: 14605461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvage robotic anterior pelvic exenteration for cervical cancer: technique and feasibility.
    Jain V; Debnath S; Rawal S
    J Robot Surg; 2021 Dec; 15(6):945-953. PubMed ID: 33515209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Robotic-assisted laparoscopic exenteration in recurrent cervical cancer Robotics improved the surgical experience for 2 women with recurrent cervical cancer.
    Davis MA; Adams S; Eun D; Lee D; Randall TC
    Am J Obstet Gynecol; 2010 Jun; 202(6):663.e1. PubMed ID: 20510970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative analysis of the prognosis of patients with locally advanced cervical cancer undergoing laparoscopic or abdominal surgery].
    Xu YP; Wang ZQ; Liang XD; Wang Y; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2020 Sep; 55(9):609-616. PubMed ID: 32957749
    [No Abstract]   [Full Text] [Related]  

  • 40. Pelvic exenteration for cervix cancer: would additional intraoperative interstitial brachytherapy improve survival?
    Beitler JJ; Anderson PS; Wadler S; Runowicz CD; Hayes MK; Fields AL; Sood B; Goldberg GL
    Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):143-8. PubMed ID: 9212016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.